GFAP and brain cancer: Koszewicz et al. evaluated a wide range of markers in a series of brain cancer patients and found the presence of several types of autoantibodies, including anti-endothelium, anti-GFAP (glial fibrillary acidic protein), and antinucleosome antibodies [23].